Click Here to return To Results

 

Lecanemab, Looking Before We Leap Neurol 101:661-665, Burke,J.F.,et al, 2023 See this aricle in Pubmed Article Abstract Before adopting lecanemab, we need to know that lecanemab is not less effective, vastly more harmful, and 100% more costly than doneprezil.

Related Tags

(click to filter results - removes previous filter) complications efficacy lecanemab review article safety

Click Here to return To Results